Skip to content

Atellica IM PTH 10995622Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · Intact Parathyroid Hormone (iPTH) Atellica IM - RGT 950T · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00630414599458), received between Mar 25, 2020 and Jan 17, 2024 — classified as 5 malfunctions.

The most frequently reported specific device problem is “High Test Results” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 4 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520264
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results4
  • No Apparent Adverse Event1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 17, 2024High Test Results; High Test Results

    THE CUSTOMER REPORTED AN OBSERVATION OF DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULTS ON MULTIPLE PATIENT(S) SAMPLES ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULTS. ALL THE SAMPLES WERE REPEATED ON ALTERNATE ATELLICA IM 1600 ANALYZERS AND THE RESULTS WERE LOWER COMPARED TO THE INITIAL RESULTS. THESE RESULTS WERE CONSIDERED AS CORRECT RESULTS BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18530630 ↗
  • MalfunctionJan 17, 2024High Test Results; High Test Results

    THE CUSTOMER REPORTED AN OBSERVATION OF A DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULT ON A PATIENT SAMPLE ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULT WAS REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULT. THIS SAMPLE WAS REPEATED ON AN ALTERNATE ATELLICA IM 1600 ANALYZER AND THE RESULT WAS LOWER COMPARED TO THE INITIAL RESULT. THIS RESULT WAS CONSIDERED AS THE CORRECT RESULT BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18530426 ↗
  • MalfunctionJan 17, 2024High Test Results; High Test Results

    THE CUSTOMER REPORTED AN OBSERVATION OF DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULTS ON MULTIPLE PATIENT(S) SAMPLES ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULTS. ALL THE SAMPLES WERE REPEATED ON ALTERNATE ATELLICA IM 1600 ANALYZERS AND THE RESULTS WERE LOWER COMPARED TO THE INITIAL RESULTS. THESE RESULTS WERE CONSIDERED AS CORRECT RESULTS BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18530403 ↗
  • MalfunctionJan 17, 2024High Test Results; High Test Results

    THE CUSTOMER REPORTED AN OBSERVATION OF DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULTS ON MULTIPLE PATIENT(S) SAMPLES ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULTS. ALL THE SAMPLES WERE REPEATED ON ALTERNATE ATELLICA IM 1600 ANALYZERS AND THE RESULTS WERE LOWER COMPARED TO THE INITIAL RESULTS. THESE RESULTS WERE CONSIDERED AS CORRECT RESULTS BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18530121 ↗
  • MalfunctionMar 25, 2020No Apparent Adverse Event; No Apparent Adverse Event

    A DISCORDANT LOW RESULT WAS OBSERVED ON AN ATELLICA IM INTACT PARATHYROID HORMONE (PTH) SAMPLE THAT HAD BEEN PREVIOUSLY FROZEN AT -24 C. THE SAMPLE WAS REPEATED THE FOLLOWING DAY AFTER CENTRIFUGATION RESULTING HIGHER. THE HIGHER RESULT WAS REPORTED TO THE PHYSICIAN(S) AS THE CORRECT RESULT. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE DISCORDANT PTH RESULT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9878861 ↗

Other RADIOIMMUNOASSAY, PARATHYROID HORMONE devices

All RADIOIMMUNOASSAY, PARATHYROID HORMONE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page